Q2SM Biomarker Development Services

The expertise, experience, and tools to maximize your biomarker strategy throughout your product’s development.

Q2SM Tailored solutions for the right biomarker strategy

As part of Q2 Solutions end-to-end biomarker capabilities, we harness our bioanalytical capabilities to aid in the development and implementation of biomarkers.

Q2 Solutions is one of the few bioanalytical laboratories successfully employing immunoprecipitation techniques and multidimensional liquid chromatography (LC) for biomarker quantitation. Our team has the experience and knowledge in development and validation of definitive quantitation addressing endogenous analytes including proteins, peptides, lipids, neurotransmitters, steroids, amino acids, and other biomarker analytes. The development of these assays is followed by method validation or qualification, and sample analysis consistent with global regulatory requirements and governed by SOPs.

Delivery excellence to identify & integrate biomarkers

We have a broad set of capabilities to support biomarker identification and analysis.

Our LC/MS Bioanalytical Biomarker Services include:
  • Method development
  • Method qualification – “fit-for-purpose” and definitive validation
  • Automated immunoprecipitation technology
  • Enzyme activity assays
  • Sample analysis supporting clinical and non-clinical studies

Shaping outcomes

Q2 Solutions is your partner of choice for any development program which requires identifying or measuring biomarkers. Through our experience and expertise we can help you understand how these biomarkers can deliver actionable medical insights for better health. Since 2015 Q2 Solutions has validated >450 new assays including over 250 biomarker assays each year.

Learn more about our end-to-end biomarker services.
Validated bioanalytical methods list

LC/MS/MS Methods, Immunoassay Biomarker Methods and LC/MS Biomarker Methods

Best Practices for Integrating Biomarkers across the Drug Development Continuum

A roadmap for a successful biomarker strategy

In Vitro ADME & Metabolite Identification Services List

Services to support your In Vitro ADME development needs

Q2 Solutions Central Laboratory Services

Optimized logistics, deeper science, better insights

Using Cyclic Nucleotides to Assess Endogenous Dilution Accuracy as a Measure of Biomarker Selectivity in LC/MS/MS

Accurate measurements of cAMP and cGMP as a useful biomarkers for development of therapeutics for a variety of indications

Read More